5:23 PM
 | 
Sep 14, 2012
 |  BC Extra  |  Company News

Bayer to acquire Teva's U.S. animal health business

Bayer AG (Xetra:BAYN) will acquire the animal health business of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) for $60 million up front, plus up to $85 million in...

Read the full 118 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >